BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krzyżek P, Franiczek R, Krzyżanowska B, Łaczmański Ł, Migdał P, Gościniak G. In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains. Pathogens 2019;8:E228. [PMID: 31717683 DOI: 10.3390/pathogens8040228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Caldara M, Marmiroli N. Antimicrobial Properties of Antidepressants and Antipsychotics-Possibilities and Implications. Pharmaceuticals (Basel) 2021;14:915. [PMID: 34577614 DOI: 10.3390/ph14090915] [Reference Citation Analysis]
2 Foletto VS, da Rosa TF, Serafin MB, Bottega A, Hörner R. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review. Int J Antimicrob Agents 2021;58:106380. [PMID: 34166776 DOI: 10.1016/j.ijantimicag.2021.106380] [Reference Citation Analysis]
3 Krzyżek P. Toxin-Antitoxin Systems - A New Player in Morphological Transformation of Antibiotic-Exposed Helicobacter pylori? Front Cell Infect Microbiol 2021;11:670677. [PMID: 33981631 DOI: 10.3389/fcimb.2021.670677] [Reference Citation Analysis]
4 Krzyżek P, Paluch E, Gościniak G. Synergistic Therapies as a Promising Option for the Treatment of Antibiotic-Resistant Helicobacter pylori. Antibiotics (Basel) 2020;9:E658. [PMID: 33007899 DOI: 10.3390/antibiotics9100658] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Krzyżek P, Migdał P, Paluch E, Karwańska M, Wieliczko A, Gościniak G. Myricetin as an Antivirulence Compound Interfering with a Morphological Transformation into Coccoid Forms and Potentiating Activity of Antibiotics against Helicobacter pylori. Int J Mol Sci 2021;22:2695. [PMID: 33800082 DOI: 10.3390/ijms22052695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Krzyżek P, Grande R. Transformation of Helicobacter pylori into Coccoid Forms as a Challenge for Research Determining Activity of Antimicrobial Substances. Pathogens 2020;9:E184. [PMID: 32143312 DOI: 10.3390/pathogens9030184] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
7 Krzyżek P, Junka A, Słupski W, Dołowacka-Jóźwiak A, Płachno BJ, Sobiecka A, Matkowski A, Chodaczek G, Płusa T, Gościniak G, Zielińska S. Antibiofilm and Antimicrobial-Enhancing Activity of Chelidonium majus and Corydalis cheilanthifolia Extracts against Multidrug-Resistant Helicobacter pylori. Pathogens 2021;10:1033. [PMID: 34451497 DOI: 10.3390/pathogens10081033] [Reference Citation Analysis]
8 Krzyżek P, Gościniak G, Fijałkowski K, Migdał P, Dziadas M, Owczarek A, Czajkowska J, Aniołek O, Junka A. Potential of Bacterial Cellulose Chemisorbed with Anti-Metabolites, 3-Bromopyruvate or Sertraline, to Fight against Helicobacter pylori Lawn Biofilm. Int J Mol Sci 2020;21:E9507. [PMID: 33327555 DOI: 10.3390/ijms21249507] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Belica-Pacha S, Daśko M, Buko V, Zavodnik I, Miłowska K, Bryszewska M. Thermodynamic Studies of Interactions between Sertraline Hydrochloride and Randomly Methylated β-Cyclodextrin Molecules Supported by Circular Dichroism Spectroscopy and Molecular Docking Results. Int J Mol Sci 2021;22:12357. [PMID: 34830239 DOI: 10.3390/ijms222212357] [Reference Citation Analysis]
10 Jampilek J. Drug repurposing to overcome microbial resistance. Drug Discov Today 2022:S1359-6446(22)00193-3. [PMID: 35561965 DOI: 10.1016/j.drudis.2022.05.006] [Reference Citation Analysis]